In 1928, it was discovered that copper was essential for normal human metabolism. A decade later, in 1938, it was observed that patients with rheu matoid arthritis exhibited a higher than normal serum copper concentration that returned to normal with remission of this disease. Thirteen years later, it was found that copper complexes were effective in treating arthritic dis eases. The first report that copper complexes had antiinflammatory activity in an animal model of inflammation appeared twenty-two years after the dis covery of essentiality. In 1976, it was suggested that the active forms of the antiarthritic drugs are their copper complexes formed in vivo. This sugges tion has been confirmed and extended in the interim in over 200 recent publications. Individual biomedical scientists from many countries who have published in these areas recently saw a need for a meeting to exchange current re supporting new hypotheses. We search results and discuss the evidence met on the University of Arkansas Medical Sciences campus in Little Rock, Arkansas, August 10-13, 1981. Participants came from Australia, England, France, Germany, Israel, Italy, The Netherlands, Norway, Poland, Scotland, Sweden, Switzerland, Wales, Zimbabwe, and over twenty of the United States."

Guest edited by Dr. Brian Mandell, this issue of Medical Clinics of North America will cover several key areas of interest related to Rheumatology. This issue is one of six selected each year by our series Consulting Editor, Dr. Jack Ende. Articles in this issue include but are not limited to: Vaccinations in Patients with Rheumatic Disease: Consider Disease and Therapy, Rheumatic Complications of Immune Checkpoint Inhibitors, Managing the Cardiovascular Risk in Patients with Rheumatic Disease, Statin associated myalgias and muscle injury - recognizing and managing both while still lowering the low-density lipoprotein, Perioperative Management of Rheumatic Disease and Therapies, Fibromyalgia: Recognition and Management in the Primary Care Office, Management and Cure of Gouty Arthritis, Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica, Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy, Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus and Obstetrical Antiphospholipid Syndrome, Rheumatoid Arthritis: Early Diagnosis and Treatment, Management of Knee Osteoarthritis: What Internists Need to Know, Antinuclear antibody (ANA) testing for the diagnosis of Systemic Lupus Erythematosus (SLE), and more.

In this issue of Rheumatic Disease Clinics, guest editors Drs. Eli Miloslavsky and Anisha Dua bring their considerable expertise to the topic of Vasculitis. Top experts in the field cover key topics such as vasculitis mimics and other related conditions; vasculitis and pregnancy: disease state and medication management; CNS vasculitis: PACNS and CNS manifestations of systemic vasculitis; ENT manifestations of vasculitis; isolated aortitis workup and management; and more. Contains 14 relevant, practice-oriented topics including peds vasculitis: Kawasaki's and COVID MIS-C; emerging therapies EGPA; managing immunosuppression in vasculitis patients in the time of COVID; future of vasculitis: DEI in vasculitis clinical trials, pathway targets, precision medicine, PROs, models for damage/relapse, biomarkers; and more. Provides in-depth clinical reviews on vasculitis, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

The book summarizes recent advances in the elucidation of the mechanisms involved in senile osteoporosis as well as its potential treatment, bringing an integrated approach from the bench to the clinical practice. A unique aspect of this book is its emphasis on the application of translational research in the field of osteoporosis and falls which make it useful not only to biologists but also to clinicians and epidemiologists. The chapters are complemented with color figures showing the basics of bone biology, bone phenotypes and falls prevention interventions and also include tables and flowcharts. Written by investigators (clinicians and basic scientists) in the field of aging bone research, this is a reference guide to geriatricians, gerontologists, endocrinologists, rheumatologists and bone biologists, medical trainees as well as other health professionals (pharmacists, physiotherapists, etc).

Musculoskeletal Imaging Volume 1 provides a comprehensive review of the subject matter commonly encountered by practicing radiologists and radiology residents in training. This volume includes succinct overviews of trauma, arthritis, and tumor and tumor-like conditions. Part of the Rotations in Radiology series, this book offers a guided approach to imaging diagnosis with examples of all imaging modalities complimented by the basics of interpretation and technique and the nuances necessary to arrive at the best diagnosis. Each pathology is covered with a targeted discussion that reviews the definition, clinical features, anatomy and physiology, imaging techniques, differential diagnosis, clinical issues, key points, and further reading. This organization is ideal for trainees' use during specific rotations, for exam review, or as a quick refresher for the established musculoskeletal imager. It is a must-read for residents and practicing radiologists seeking a foundation for the essential knowledge base in musculoskeletal imaging. Musculoskeletal Imaging Volume 2 reviews metabolic, infectious, and congenital diseases; internal derangement of joints; and arthography, and ultrasound.

Orthopedics and rheumatology, while separate specialties, have become close conceptually because advances in bone and joint biology enable practitioners to approach clinical problems comprehensively. This is especially true for the bench and translational scientists. Recently, there has been renewed interest in the role played by bone in the development of osteoarthritis, including targeting bone as a potential therapeutic approach.

The molecular and cellular approaches toward the relationship of joint and bone problems distinguish this from other books on osteoarthritis or skeletal medicine. Emphasis on genetics and on newer viewpoints and approaches, exemplified by the possible effect of subchondral bone on osteoarthritis, gives a wider viewpoint to the reader and may make possible novel approaches to solving a clinical problem. The book will therefore also interest experienced specialists, thereby broadening readership. Authors are internationally recognized experts in their field.

Topics discussed include the role of bone in osteoarthritis, ranging from basic cell and molecular biology to genetics and biomechanics. How this information may be used for new treatment approaches will also be covered.

This book, intended for students, researchers and clinicians, provides information that enables the novice to become oriented and the practitioner to update knowledge. No other book combines information on the relationship of bone to the development of osteoarthritis, or treats the pathophysiology of joints in the same way. This volume, like the others in Topics in Bone Biology series, encompasses aspects of many specialties, including rheumatology, orthopedics, endocrinology, oncology, dentistry, geriatrics, nursing and chiropractic medicine.

In 1928, it was discovered that copper was essential for normal human metabolism. Ten years later, 1938, it was observed that patients with rheumatoid arthritis had a higher than normal serum copper concentration, which returned to normal wi th remission of this disease. Thirteen years later, it was found that copper complexes were effective in treating arthritic diseaseS. The first report that copper complexes had antiinflammatory activity in an animal model of in flammation appeared twenty-two years after the discovery of essen tiality. In 1976, it was suggested that the active forms of the anti arthritic drugs are their copper complexes formed in vivo. This suggestion was confirmed and extended in the interim with over 1000 recent publications, and many of these were addressed in the proceed ings of our first symposium, published in 1982. The present symposium was organized to present new normal physiological, nutritional, and biochemical aspects of essential metal loelement metabolism as well as variations in metabolism associated with disease states. In addition new data concerning antimicrobial, antiinflammatory, antiulcer, anticancer, anticarcinogenic, analgesic, and radioprotectant activities of copper complexes were presented. These activities are consistent with the notion that they represent the facilitation of normal copper-dependent metabolic processes in dis ease states. The presentations and interactive discussions that fol lowed are contained in these proceedings. John R. J. Sorenson Dedication These proceedings are dedicated to those who made this truly memorable scientific and social Arkansas experience possible."

Electromyography (EMG) and nerve conduction studies (NCS) are electrodiagnostic tests used for identifying neuromuscular diseases and for assessing low-back pain and disorders of motor control. Many doctors refer their patients to the clinical neurophysiology department for electrodiagnostic tests and are then faced with interpreting the results. This book teaches the principles of NCS and EMG, promotes better understanding of the strengths and weaknesses of these techniques, and thereby improves their use. Understanding EMG is different from existing books in this field since it is written for a large group of referring doctors and other healthcare professionals who need to know the basic principles of NCS and EMG, including when to request and how to interpret the tests, but who do not necessarily need to know how to perform them.

Bringing together the most up-to-date research on post-traumatic arthritis (PTA) and its management, this book is a comprehensive presentation of the current thinking on all aspects of the mechanisms of joint injury and subsequent development of PTA. Divided into thematic sections, it includes discussions of the incidence and burden of PTA, both in society at large and in the military population specifically; the relevant experimental work on PTA, from basic science to animal models; peri-articular tissue responses to of joint injury and potential mechanisms of PTA; the current clinical assessment and treatment of common joint injuries leading to PTA; and emerging technologies and treatments for PTA, including biomarkers and stem cell therapies. Taken together, it will be an invaluable resource for orthopedic surgeons, rheumatologists and other joint injury researchers and clinicians.

Recent concern about the adverse effects and relative risks of anti- inflammatory therapies has been such that another meeting was organized in the highly successful series of meetings on this topic. Adverse effects of anti-rheumatic and anti-inflammatory drugs are of major concern to all involved in the prescription, care and management of rheumatic and other patients receiving these important drugs. The IVth International Meeting on Side-Effects of Anti-Inflammatory Drugs, held in Sheffield, UK, 7-9 August 1995, afforded a unique opportunity to hear the latest information and views on issues concerning the development of adverse effects from these drugs, the management of these effects, and the development of safer therapies. In addition to discussions on the safety relative to efficacy of established non-steroidal and steroidal anti-inflammatory drugs and disease-modifying agents, there was detailed consideration of the novel cyclo-oxygenase-2 selective NSAIDs which have recently been developed and introduced to the clinic. Also, the side effects from therapy with biologics, notably monoclonal antibodies and oral tolerance therapies, were considered. Among the other highlights in the programme were: Clinico-epidemiological studies on the adverse effects relative to use/efficacy of established and new anti-rheumatic drugs. Procedures for reducing the gastrointestinal adverse effects. Mechanisms and clinical significance of adverse effects in the gastrointestinal tract, liver, kidney, articular joints, skin and other organs from NSAIDs. Clinical status and mechanisms of action of the newer (third generation) of NSAIDs (e.g. etodolac, nabumetone, meloxicam). Medico-legal aspects ofadverse effects from anti-rheumatic drugs. The concept of conditional pharmacology' or the disease-dependence of the toxicological and pharmacological activity of the anti-inflammatory drugs. The papers in this book were selected from those presented at the meeting.

This book provides a detailed overview of B-cell directed therapies in patients with rheumatic and systemic autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sjoegren syndrome, ANCA-associated vasculitis and cryoglobulinemia. Organ-specific autoimmune diseases are discussed with respect to the use of B-cell directed therapies in neurological autoimmune diseases and autoimmune cytopenias. Situations in which B-cell targeted therapy may be indicated are identified, thereby offering comprehensive support for therapeutic decisions on the basis of the latest published evidence. The book also offers a valuable reference tool for rheumatologists, internists, nephrologists, immunologists, and all specialists involved in the multidisciplinary care of patients with rheumatic and systemic autoimmune diseases.

Characterized by chronic widespread pain, fibromyalgia presents complex problems in both its diagnosis and treatment. Fibromyalgia is a fairly common condition, affecting 2-4% of the population. The condition's prevalence has increased dramatically since 1990. The condition is not new, but has been known by various names, such as fibrositis and myofascial pain syndrome until 1990, when the American College of Rheumatology (ACR) published new classification criteria and first used the name fibromyalgia. The absence of objective diagnostic testing and the overlap with other condition often leads to a significant delay in diagnosis. There is a general misconception that the condition is unresponsive to treatment. However, published research shows that diagnosing and managing fibromyalgia leads to meaningful improvement in the patient's symptons and quality of life.
Patients with fibromyalgia often demonstrate symptons additional to pain and are consquently diagnosed with one or more co-occurring syndromes and conditions, complicating diagnosis and treatment. The comorbidities most commonly associated wtih fibromyalgia are sleep disturbance, depression, anxiety, and other psychiatric disorders. Another condition frequently demonstrated by fibromylgia patients is irritable bowel syndrome. Chronic fatigue syndrome also commonly co-occurs, and is often confused wtih fibromyalgia upon initial diagnosis. Numerous pharmacological therapy options exist to treat pain and related symptons of fibromyalgia. Achievement of desired treatment outcomes requires careful patient selection, drug administration and monitoring. Accurate diagnosis of chronic pain syndromes is critical, as some commonly used medications to treat many pain conditions are relatively ineffective wtih fibromyalgia.
Despite increasing recognition as a relatively common cause of chronic pain, fibromyalgia continues to generate controversy among clinicians. Given the intricate and challenging nature of treating fibromyalgia and comorbid disorders, it is imperative to educate primary care providers on the initial symptons, complications, and treatment strategies for fibromyalgia, as most patients with the condition will see a primary care provider for initial diagnosis/referral, and follow-up-care. In the years since the release of the ACR criteria, increasing recognition and advances in research have provided key insights into the etiology of fibromyalgia, resulting in the use of several successful pharmacological, as well as non-pharmacological, treatment approaches. However, despite the efforts of professional medical organizations and patient care groups, awareness of the current state of clinical assessment and treatment of fibromyalgia by healthcare professionals continues to be lacking.
This book is designed to provide a succint and practical guide to help primary care physicians, internists, specialists, and allied health professionals effectively diagnose and manage patients with fibromyalgia. This concise volume will provide an essential understanding of the pathophysiology of the pain, subtypes, and pitfalls in the diagnosis of this chronic condition.

Back Pain: The Facts is aimed at people who want to help themselves. Affecting nearly everyong at some time in their lives, 40% of people will have experienced some form of back pain within the last year, with around 5% of sufferers taking time off from work within the last month. Long term back pain causes a great deal of distress and unhappiness, affecting work life, income, home life, relationships, fitness, and mood.
Back Pain: The Facts uses clear succinct chapters to give advice about every aspect of managing back pain, as well as answering frequently asked questions from sufferers. A key element is empowerment through understanding why back pain starts and why it persists. There are chapters promoting stretching, exercise, relaxation, communication, advice on sexual relations, as well as considerable emphasis on helping with thoughts and feelings.

This book provides a practically applicable manual to the utilisation of ultrasound in rheumatology. Each chapter includes high-quality diagrams of each anatomical region covered, accompanied by an ideal scan with written and pictorial demonstrations, as well as an ideal ultrasound image, that has been obtained via a high-end machine for optimal image quality. This systematic approach to describing the application of ultrasound in rheumatology enables the reader to develop a deep understanding of how to correctly make use of ultrasound technologies in their daily practice. Ultrasound in Rheumatology: A Practical Guide for Diagnosis is an easy to follow guide to the application of ultrasound in rheumatology and is a valuable resource for the trainee and practising rheumatologist seeking a guide on the correct use of ultrasound.

Perioperative care of the patient with a multisystem inflammatory (rheumatic) disease has become increasingly complex and perioperative medicine has evolved into its own subspecialty. Physicians who have expertise in managing patients with rheumatic disease infrequently spend significant time also managing patients undergoing surgical procedures, and the reverse is equally true. Despite the burgeoning literature on the medical management of the surgical patient, scant data have been generated regarding patients with complex rheumatic disease. Perioperative Management of Patients with Rheumatic Disease fills a conspicuous gap in the literature and aims at providing a paved path for rheumatologists--who infrequently manage surgical problems--and medical consultants--who only seldom encounter patients with rheumatic diseases--to tread as they care for patients in the perioperative period. The book addresses discrete management issues from the perspective of the medical subspecialist and also offers concise descriptions of surgical procedures. Written from the surgical perspective for the internist, the surgical procedure chapters include a brief description of relative contraindications, time to recovery, rehabilitation suggestions, and comments regarding common and severe procedure specific postoperative complications.

This book will address the growing roles of epigenetics in disease pathogenesis, and review the contribution of epigenetic modifications to disease onset and progression. The roles that epigenetics plays in facilitating effects of the environment on allergy and immunologic diseases will be reviewed. The book is divided into three parts - the first is an introduction to epigenetics and the methods that have been developed to study epigenetics, the second addresses epigenetics in allergic diseases and the third part will cover epigenetics in autoimmune diseases. With the rapid expansion of knowledge of how genes are regulated and how this regulation affects disease phenotypes, this book will be attractive to experienced researchers as well as those just launching an epigenetics research program. It will also be of interest to allergist, immunologists, rheumatologists and dermatologist who are engaged in clinical practice as a resource for understanding the basis for personalized and precision medicine. For example, the role that epigenetics plays in the pathogenesis in various allergic and autoimmune disorders and how this determines disease phenotypes will be covered extensively in this book. This book will thus help fill the gap in available resources on epigenetics in allergy and autoimmune diseases.

An indispensable collection of updated classical and emerging techniques that promise to add critical knowledge to our understanding of cartilage metabolism in health and disease. Volume 1: Cellular and Molecular Tools describes proven molecular and cellular techniques for the in vitro study of normal and osteoarthritic cartilage through biochemical, biomolecular, immunological, and physical approaches, with emphasis on the genetic manipulation of cells. Volume 2: Structure and In Vivo Analysis, offers cutting-edge procedures for the study-at the tissue level-of turnover, structure, and functioning of normal and diseased articular cartilage by invasive and noninvasive means. Comprehensive and up-to-date, the two volumes of Cartilage and Osteoarthritis provide researchers and bench scientists with readily reproducible protocols for new experiments to understand-from the cellular to the animal level-the pathophysiology of cartilage and to discover molecular targets for pharmacological intervention.

The Digestive System in Systemic Autoimmune Diseases, Second Edition, represents the state-of-the-art in the field of digestive disorders in the most common systemic autoimmune diseases. This volume consists of an introductory chapter on imaging techniques in digestive diseases, followed by eight chapters on digestive manifestations in specific systemic autoimmune diseases. The final five chapters deal with digestive diseases with an autoimmune pathogenesis and systemic manifestations. International in scope, the table of contents reads like a Who's who in clinical research on systemic autoimmune diseases. More than 20 contributors from the European Union, the United States, Mexico, and South Africa share their knowledge in this detailed volume. The book provides an overview of our current understanding of digestive disorders in the most common systemic autoimmune diseases.

A Visual Guide to Scleroderma and Approach to Treatment offers a focused analysis of the diagnosis and management of scleroderma. Specifically designed to enlighten and update students and trainees, practicing rheumatologists and general practitioners on the various forms of systemic sclerosis, the book is designed to be an easily accessible tool that also covers potential complications and the latest treatment developments. A Visual Guide to Scleroderma and Approach to Treatment emphasizes recognition of common clinical features by focusing on and illustrating severe and less severe forms of the disease that can involve internal organs such as the gastrointestinal tract, heart, lungs and kidneys. Photos and radiographs introduce each chapter and are accompanied by a guide to workup and treatment. A comprehensive and invaluable addition to the literature, this text is not only a necessary resource for students, trainees and primary care physicians; it will also be of significant interest to specialists in the fields of rheumatology, dermatology, pulmonology, cardiology, gastroenterology and nephrology.

Nutritional Influences on Bone Health presents a collection of papers from the 8th International Symposium on Nutritional Aspects of Osteoporosis, the primary forum for and only regular meeting exclusively devoted to the topic of nutritional influences on bone health. The outcome is a fusion of the most current and up-to-date research in this area. Key themes include the permeation of the Western diet across the globe, calcium, vitamin D and acid-base balance. Written by authorities on the impact of nutrition on bone health, Nutritional Influences on Bone Health brings the reader the emerging trends, new messages and the latest scientific data in the field, to inform future research and clinical practice. This comprehensive, well researched volume is an essential reference for professionals in the field of bone health and nutrition.

This issue of Rheumatic Disease Clinics, guest edited by Dr. Alfred Kim and Zahi Touma, will discuss a number of key topics surrounding Lupus. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discussed in this issue include, but are not limited to: Interferons in SLE, NETosis and neutrophils in SLE, AMP update in lupus nephritis, Patient-reported outcomes, Complement, T cells in SLE, B cells in SLE, Outcome measures for SLE clinical trials, Mitochondrial physiology in SLE, Pregnancy, Lupus cohorts, Innovative trials and new opportunities in SLE, Classification and diagnosis of SLE, and Updates on SLE Treatment.

Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy.